Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
49 46 Search
2025
Evaluating phytochemicals as SARS-CoV-2 papain-like protease inhibitors: a docking, ADMET and molecular dynamics investigation
Chemical Papers
2025
Network-Driven Methods Using Gene Expression Signatures to Find Therapeutic Targets in Breast Cancer Validated via Molecular Dynamics Studies
Journal of Chemical Information and Modeling
2025
Review of the crystallized structures of the SARS-CoV-2 papain-like protease
Journal of Molecular Structure
2024
Integrated virtual screening and molecular dynamics simulation approaches revealed potential natural inhibitors for DNMT1 as therapeutic solution for triple negative breast cancer
Journal of Biomolecular Structure and Dynamics
2024
Evolution of drug resistance against antiviral agents that target cellular factors
Virology
2024
Structure-based virtual screening of natural compounds as inhibitors of HCV using molecular docking and molecular dynamics simulation studies
Journal of Biomolecular Structure and Dynamics
2024
Identification of Novel Drug Molecules Against NS3-Like Helicase Enzyme of Alongshan Virus
Molecular Biotechnology
2023
Molecular Docking Studies of Boron‐Containing Compounds as Dual Inhibitors of SARS‐Cov‐2 Spike Receptor Binding Domain/ACE2 Complex and Main Protease and ADMET Investigations
ChemistrySelect
2023
COVID-19 signalome: Potential therapeutic interventions
Cellular Signalling
2023
<i>In Silico</i> Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease
Chemical and Pharmaceutical Bulletin
2023
In Silico Analysis of the Antidepressant Fluoxetine and Related Drugs at SARS-CoV-2 Main Protease (Mpro) and Papain-like Protease (PLpro)
Current Drug Discovery Technologies
2023
Integrated molecular modeling and dynamics approaches revealed potential natural inhibitors of NF-κB transcription factor as breast cancer therapeutics
Journal of Biomolecular Structure and Dynamics
2023
DrugRep-HeSiaGraph: when heterogenous siamese neural network meets knowledge graphs for drug repurposing
BMC Bioinformatics
2022
DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design
Molecules
2022
Network analytics for drug repurposing in COVID-19
Briefings in Bioinformatics
2022
Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone
Frontiers in Chemistry
2022
Identification of molecular mechanisms underlying the therapeutic effects of Celosia Cristata on immunoglobulin nephropathy
Computers in Biology and Medicine
2022
Strategies for drug repurposing against coronavirus targets
Current Research in Pharmacology and Drug Discovery
2022
Biotechnology in Healthcare, Volume 1
2022
A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease
Neurotoxicity Research
2022
Potential SARS-CoV-2 Spike Protein-ACE2 Interface Inhibitors: Repurposing FDA-approved Drugs
Journal of Exploratory Research in Pharmacology
2022
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
Acta Pharmaceutica Sinica B
2022
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Canadian Journal of Infectious Diseases and Medical Microbiology
2022
Discovery of Rift Valley fever virus natural pan-inhibitors by targeting its multiple key proteins through computational approaches
Scientific Reports
2022
Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors
Pharmaceuticals
2022
Potential therapeutic drug candidates against SARS-CoV-2 (COVID‐19) through molecular docking: A review
Health Science Monitor
2022
In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2
Journal of Biomolecular Structure and Dynamics
2022
Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning
Frontiers in Bioscience-Landmark
2022
The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects
Biophysical Chemistry
2022
Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness/ADMET studies
Saudi Journal of Biological Sciences
2021
Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
Precision Clinical Medicine
2021
Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations
ACS Chemical Neuroscience
2021
2021 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB)
2021
Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19
Scandinavian Journal of Immunology
2021
Investigating Fungi-Derived Bioactive Molecules as Inhibitor of the SARS Coronavirus Papain Like Protease: Computational Based Study
Frontiers in Medicine
2021
Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study
Computers in Biology and Medicine
2021
Drug repurposing: new strategies for addressing COVID-19 outbreak
Expert Review of Anti-infective Therapy
2021
Science's Response to CoVID‐19
ChemMedChem
2021
Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
Future Microbiology
2021
Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes
Best Practice & Research Clinical Rheumatology
2021
Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19
Naunyn-Schmiedeberg's Archives of Pharmacology
2021
The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study
PeerJ
2021
Using informative features in machine learning based method for COVID-19 drug repurposing
Journal of Cheminformatics
2021
Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CLPRO proteases
European Journal of Pharmacology
2021
Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2
Molecules
2021
Advances in the computational landscape for repurposed drugs against COVID-19
Drug Discovery Today
2021
Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates
Bioscience Reports
Additional cited-by details will be shown when available from Crossref